Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (181-190 of 667) with videos related to

Pageof 67
Sort By:
Frontiers in Oncology|March 15, 2021
Overexpression of ABCC1 Confers Drug Resistance to BetulinXuan-Yu Chen, Yuqi Yang, Jing-Quan Wang, et al.
Cancer Letters|March 14, 2012
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cellsXian-Jun Yu, Quan-Bin Han, Zhe-Sheng Wen, et al.
Molecules (Basel, Switzerland)|September 6, 2014
Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistanceNagaraju Anreddy, Pranav Gupta, Rishil J Kathawala, et al.
Medical Oncology (Northwood, London, England)|November 8, 2014
Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinomaYou-Fang Chen, Gang Ma, Xun Cao, et al.
Frontiers in Pharmacology|February 8, 2024
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapyLu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Biochimica Et Biophysica Acta|March 20, 2016
Cytokines in cancer drug resistance: Cues to new therapeutic strategiesValerie Sloane Jones, Ren-Yu Huang, Li-Pai Chen, et al.
Recent Patents on Anti-Cancer Drug Discovery|December 1, 2021
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast CancerMinling Liu, Lei Li, Shan Huang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 10, 2007
[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection]Wei-Dong Wei, Zhe-Sheng Wen, Xiao-Dong Su, et al.
Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.
Frontiers in Pharmacology|May 2, 2022
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An UpdateZoufang Huang, Vivek P Chavda, Lalitkumar K Vora, et al.
Pageof 67

Showing results (181-190 of 667) with videos related to

Sort By:
Pageof 67
Frontiers in Oncology|March 15, 2021
Overexpression of ABCC1 Confers Drug Resistance to BetulinXuan-Yu Chen, Yuqi Yang, Jing-Quan Wang, et al.
Cancer Letters|March 14, 2012
Gambogenic acid induces G1 arrest via GSK3β-dependent cyclin D1 degradation and triggers autophagy in lung cancer cellsXian-Jun Yu, Quan-Bin Han, Zhe-Sheng Wen, et al.
Molecules (Basel, Switzerland)|September 6, 2014
Tyrosine kinase inhibitors as reversal agents for ABC transporter mediated drug resistanceNagaraju Anreddy, Pranav Gupta, Rishil J Kathawala, et al.
Medical Oncology (Northwood, London, England)|November 8, 2014
Downregulated expression of PTK6 is correlated with poor survival in esophageal squamous cell carcinomaYou-Fang Chen, Gang Ma, Xun Cao, et al.
Frontiers in Pharmacology|February 8, 2024
Therapeutic evolution in HR+/HER2- breast cancer: from targeted therapy to endocrine therapyLu-Qi Cao, Haidong Sun, Yuhao Xie, et al.
Biochimica Et Biophysica Acta|March 20, 2016
Cytokines in cancer drug resistance: Cues to new therapeutic strategiesValerie Sloane Jones, Ren-Yu Huang, Li-Pai Chen, et al.
Recent Patents on Anti-Cancer Drug Discovery|December 1, 2021
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast CancerMinling Liu, Lei Li, Shan Huang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|November 10, 2007
[Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection]Wei-Dong Wei, Zhe-Sheng Wen, Xiao-Dong Su, et al.
Biochemical Pharmacology|December 25, 2012
The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Jasjeet Bhullar, Suneet Shukla, et al.
Frontiers in Pharmacology|May 2, 2022
2-Deoxy-D-Glucose and its Derivatives for the COVID-19 Treatment: An UpdateZoufang Huang, Vivek P Chavda, Lalitkumar K Vora, et al.
Pageof 67